Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-14 Sale | 2021-12-16 9:30 pm | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 355,705 | $67 | $23,833,381 | 185,686 (Indirect) | View |
| 2021-11-10 Sale | 2021-11-15 9:45 pm | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 134,310 | $85.83 | $11,527,510 | 541,391 (Indirect) | View |
| 2021-11-05 Sale | 2021-11-09 9:47 pm | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 172,079 | $93.02 | $16,006,424 | 675,701 (Indirect Direct) | View |
| 2020-12-18 Purchase | 2020-12-21 6:00 pm | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 142,857 | $70 | $9,999,990 | 822,857 (Indirect) | View |
| 2020-03-03 Purchase(A) | 2020-03-13 5:20 pm | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 552,800 | $18 | $9,950,400 | 2,619,430 (Indirect Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:48 pm | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 2,800 | $18 | $50,400 | 2,800 (Direct) | View |
| 2019-11-12 Purchase | 2019-11-14 4:23 pm | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 680,000 | $22 | $14,960,000 | 680,000 (Indirect) | View |
| 2018-10-01 Purchase | 2018-10-03 5:22 pm | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 1,000,000 | $16 | $16,000,000 | 375,000 (Indirect) | View |
| 2018-06-25 Purchase | 2018-06-26 4:53 pm | Aptinyx Inc. | APTX | Ratcliffe Liam Director 10% Owner | 250,000 | $16 | $4,000,000 | 368,345 (Indirect) | View |
| 2018-05-30 Purchase | 2018-05-31 4:54 pm | Iterum Therapeutics plc | ITRM | Lathi Vijay K Ratcliffe Liam 10% Owner | 662,677 | $13 | $8,614,801 | 384,615 (Indirect) | View |
| 2018-04-03 Purchase | 2018-04-03 4:30 pm | Unum Therapeutics Inc. | UMRX | Ratcliffe Liam Director | 550,000 | $12 | $6,600,000 | 897,773 (Indirect) | View |
| 2017-10-02 Purchase | 2017-10-02 4:40 pm | Deciphera Pharmaceuticals Inc. | DCPH | Ratcliffe Liam Director 10% Owner | 375,000 | $17 | $6,375,000 | 2,146,308 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-16 Option Award | 2022-06-21 8:00 pm | N/A 2032-06-15 | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 10,192 | $0 | 10,192 (Direct) | View |
| 2022-05-19 Option Award | 2022-06-01 5:14 pm | N/A 2032-05-18 | Eliem Therapeutics Inc. | ELYM | Ratcliffe Liam Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-11-05 Exercise | 2021-11-09 9:47 pm | N/A N/A | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 12,000 | $33.57 | 675,701 (Direct) | View |
| 2021-11-05 Exercise | 2021-11-09 9:47 pm | N/A N/A | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 6,423 | $22.06 | 675,701 (Direct) | View |
| 2021-11-05 Exercise | 2021-11-09 9:47 pm | N/A 2029-05-22 | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 18,423 | $0 | 675,701 (Direct) | View |
| 2021-08-09 Option Award | 2021-08-11 5:23 pm | N/A 2031-08-08 | Eliem Therapeutics Inc. | ELYM | Ratcliffe Liam Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-08-09 Ownership | 2021-08-09 6:22 pm | N/A N/A | Eliem Therapeutics Inc. | ELYM | Ratcliffe Liam Director | 0 | $0 | 0 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 8:00 pm | N/A 2021-06-07 | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 7,511 | $0 | 7,511 (Direct) | View |
| 2021-05-27 Option Award | 2021-05-28 5:58 pm | N/A 2031-05-26 | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 16,918 | $0 | 16,918 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-04 9:00 pm | N/A 2030-06-02 | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2020-05-26 Exercise | 2020-05-27 6:34 pm | N/A N/A | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 6,500 | $22.06 | 692,923 (Direct) | View |
| 2020-05-26 Exercise | 2020-05-27 6:34 pm | N/A 2029-05-22 | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 6,500 | $0 | 692,923 (Direct) | View |
| 2020-03-03(A) Conversion | 2020-03-13 5:20 pm | N/A N/A | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 2,066,630 | $0 | 2,619,430 (Indirect) | View |
| 2020-02-27(A) Ownership | 2020-03-12 7:02 pm | N/A N/A | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 0 | $0 | 2,066,630 (Indirect) | View |
| 2020-02-27 Option Award | 2020-03-02 5:58 pm | N/A 2030-02-27 | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 33,836 | $0 | 33,836 (Direct) | View |
| 2019-06-14 Option Award | 2019-06-18 4:27 pm | N/A 2029-06-14 | Unum Therapeutics Inc. | UMRX | Ratcliffe Liam Director | 7,881 | $1.6654 | 7,881 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-28 5:11 pm | N/A 2029-05-22 | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 12,923 | $0 | 12,923 (Direct) | View |
| 2019-04-01 Option Award | 2019-04-03 4:32 pm | N/A 2029-04-01 | Unum Therapeutics Inc. | UMRX | Ratcliffe Liam Director | 4,829 | $2.7185 | 4,829 (Direct) | View |
| 2019-03-29 Option Award | 2019-04-02 4:24 pm | N/A 2029-03-28 | Aptinyx Inc. | APTX | Ratcliffe Liam Director | 4,123 | $2.425 | 4,123 (Direct) | View |
| 2019-03-15 Exercise | 2019-03-18 5:52 pm | N/A N/A | Edge Therapeutics Inc. | EDGE | Ratcliffe Liam Director | 10,000 | $0 | 2,354,868 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-04 4:57 pm | N/A 2029-01-02 | Unum Therapeutics Inc. | UMRX | Ratcliffe Liam Director | 4,860 | $2.7 | 4,860 (Direct) | View |
| 2018-10-01 Conversion | 2018-10-03 5:22 pm | N/A N/A | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 5,452,957 | $0 | 375,000 (Indirect) | View |
| 2018-10-01 Option Award | 2018-10-03 5:19 pm | N/A 2028-10-01 | Unum Therapeutics Inc. | UMRX | Ratcliffe Liam Director | 2,111 | $6.22 | 2,111 (Direct) | View |
| 2018-09-26 Ownership | 2018-09-26 8:53 pm | N/A N/A | ARVINAS HOLDING COMPANY LLC | ARVN | Ratcliffe Liam Director 10% Owner | 0 | $0 | 1,283,048 (Indirect) | View |
| 2018-07-26 Option Award | 2018-09-26 6:47 pm | N/A 2028-07-26 | Unum Therapeutics Inc. | UMRX | Ratcliffe Liam Director | 1,504 | $8.72 | 1,504 (Direct) | View |
| 2018-08-14 Option Award | 2018-08-15 08:05 am | N/A N/A | Edge Therapeutics Inc. | EDGE | Ratcliffe Liam Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2018-06-25 Conversion | 2018-06-26 4:53 pm | N/A N/A | Aptinyx Inc. | APTX | Ratcliffe Liam Director 10% Owner | 86,904,354 | $0 | 368,345 (Indirect) | View |
| 2018-06-20 Ownership | 2018-06-20 7:41 pm | N/A N/A | Aptinyx Inc. | APTX | Ratcliffe Liam Director 10% Owner | 0 | $0 | 3,040,079 (Indirect) | View |
| 2018-06-19 Option Award | 2018-06-20 4:54 pm | N/A N/A | Edge Therapeutics Inc. | EDGE | Ratcliffe Liam Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2018-05-30 Conversion | 2018-05-31 4:54 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Lathi Vijay K Ratcliffe Liam 10% Owner | 793,626 | $0 | 384,615 (Indirect) | View |
| 2018-05-24 Ownership | 2018-05-24 6:38 pm | N/A N/A | Iterum Therapeutics plc | ITRM | New Leaf Venture Management III L.L.C. New Leaf Venture Associates III L.P. New Leaf Ventures III L.P. Lathi Vijay K Ratcliffe Liam 10% Owner | 0 | $0 | 793,626 (Indirect) | View |
| 2018-05-17 Option Award | 2018-05-21 4:25 pm | N/A 2028-05-16 | Deciphera Pharmaceuticals Inc. | DCPH | Ratcliffe Liam Director 10% Owner | 12,000 | $0 | 12,000 (Direct) | View |
| 2018-04-03 Conversion | 2018-04-03 4:30 pm | N/A N/A | Unum Therapeutics Inc. | UMRX | Ratcliffe Liam Director | 3,201,216 | $0 | 897,773 (Indirect) | View |
| 2018-03-28 Ownership | 2018-03-28 8:58 pm | N/A N/A | Unum Therapeutics Inc. | UMRX | Ratcliffe Liam Director | 0 | $0 | 1,245,545 (Indirect) | View |
| 2017-10-02 Conversion | 2017-10-02 4:40 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Ratcliffe Liam Director 10% Owner | 3,270,443 | $0 | 2,146,308 (Indirect) | View |